MedPath

东曜药业有限公司

Ownership
-
Established
2010-07-05
Employees
-
Market Cap
-
Website
https://www.totbiopharm.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

3

NMPA:3

Drug Approvals

Bevacizumab Injection

Product Name
朴欣汀
Approval Number
国药准字S20210049
Approval Date
Nov 30, 2021
NMPA

Temozolomide Capsules

Product Name
替莫唑胺胶囊
Approval Number
国药准字H20213414
Approval Date
May 26, 2021
NMPA

Temozolomide Capsules

Product Name
替莫唑胺胶囊
Approval Number
国药准字H20213413
Approval Date
May 26, 2021
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.